Metraipolis › archive › dc_0b44b0bd30ea
Bipolar Androgen Therapy as a Potential Mechanistic Bridge to Enhance PARP Inhibitor Efficacy in Prostate Cancer — Europe PMC PMID:42753176
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42753176
- DOI
- 10.1002/kjm2.70292
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T12:21:28.408Z
- SHA-256 of the archived text
79c49b0e696ff03441931681a50f9dab4eec59f0a997894ea825f1644d9f9d36- Stable URL of this page
https://metraipolis.com/documento/dc_0b44b0bd30ea
How to cite
Bipolar Androgen Therapy as a Potential Mechanistic Bridge to Enhance PARP Inhibitor Efficacy in Prostate Cancer — Europe PMC PMID:42753176 — Europe PMC (en), https://europepmc.org/article/MED/42753176 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0b44b0bd30ea (Metraipolis archive dc_0b44b0bd30ea, sha256 79c49b0e696ff03441931681a50f9dab4eec59f0a997894ea825f1644d9f9d36)
BibTeX
@misc{dc0b44b0bd30ea,
title = {Bipolar Androgen Therapy as a Potential Mechanistic Bridge to Enhance PARP Inhibitor Efficacy in Prostate Cancer — Europe PMC PMID:42753176},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42753176},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0b44b0bd30ea; sha256 79c49b0e696ff03441931681a50f9dab4eec59f0a997894ea825f1644d9f9d36},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42753176. Agents can read the archived copy with the MCP tool read_document.